NRAS and cancer: These findings are similar to those of a prior study by Harbst et al. [24], who examined eight melanomas for genetic heterogeneity and found that 12% of the detected cancer-associated mutations were heterogeneously distributed, whereas BRAF and NRAS mutations, when detected, were homogeneously distributed among all the sampled regions.